RAB Capital

RAB Capital is a London-based investment management firm that rose to prominence as a leading hedge fund manager, particularly known for its focus on 'special situations' within the biotechnology and natural resources sectors. Founded in 1999, the firm became a significant provider of growth capital to small and mid-cap life science companies, often participating in early-stage venture rounds and private investments in public equity (PIPEs). At its peak, RAB Capital managed several billion dollars in assets and was a highly influential player in the European and North American biotech ecosystems. Following the 2008 financial crisis, the firm underwent a significant restructuring and was taken private in 2011. Today, it continues to operate as a private investment vehicle, maintaining a portfolio that includes strategic holdings in healthcare, technology, and energy.